dapagliflozin
astrazeneca
['cardio']
 no mortality benefit in #deliver. sglti reduced hf hospitalization, hf progression, and improved overall qol. see kmc below #esccongress2022 #esccongress #esc2022 #esc22 #medtwitter #cardiotwitter 
Cardiology Fellow @OHSUCardio| MSc in Clinical Trials @Oxford_NDPH '23 | MPH @Harvard | Postdoc @UPMC | ABIM @HenryFord. #ESCCongress #Medtwitter #ESCGuidelines